RECRUITING

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Description

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

Conditions

Ovarian CancerEndometrial CancerCervical CancerVulvar CancerVaginal CancerGestational Trophoblastic Disease
Talk to us

Related Conditions:

Ovarian CancerEndometrial CancerCervical CancerVulvar CancerVaginal CancerGestational Trophoblastic Disease

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

ASk Questions in GYnecologic Oncology (ASQ-GYO): A Randomized Controlled Trial of a Question Prompt List Communication Intervention in Outpatient Gynecologic Oncology Clinics

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Condition
Ovarian Cancer
Intervention / Treatment

-

Contacts and Locations

Detroit

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States, 48201

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age
  • * Understands spoken and written English
  • * Able to consent to study participation
  • * Biopsy confirmed gynecologic cancer diagnosis (ovarian, endometrial, cervical, vulvar, or vaginal cancer or Gestational Trophoblastic Disease) OR have imaging and/or laboratory findings highly concerning for a cancer diagnosis and have not seen a Gynecologic Oncologist
  • * pathologic diagnosis of dysplasia only (cervical, vulvar, or endometrial)
  • * History and/or imaging/laboratory findings more indicative of a non-cancer diagnosis
  • * Previous treatment discussion with a Gynecologic Oncologist

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ira Winer,

Ira Winer, MD PhD, PRINCIPAL_INVESTIGATOR, Barbara Ann Karmanos Cancer Institute

Study Record Dates

2027-05